When referring to this article, please cite it as Hennessy, M. How Innovation and Risk Management Are Reshaping Modern Drug ...

Technological advancements in synthetic chemistry, bioproduction, and containment are enhancing the feasibility of developing ...

Counterfeit pharmaceuticals jeopardize public health worldwide, often leading to ineffective or dangerous treatments. Enter ...

In this PharmTech video feature, we highlight the week’s industry news in an easy-to-consume, fun format. New roundups will ...

FDA has granted orphan drug designation to FS2 (kynurenic acid) for the investigational treatment of idiopathic pulmonary ...

Facility design should integrate risk mitigation strategies, focusing on contamination prevention and reliable utility ...

Several European biotechs, including Cellbox Labs, Evotec SE, Nanolive SA, and Salipro Biotech AB, have developed innovative ...

Large-language models are excellent for general-use AI systems, but they don’t understand pharmaceutical companies’ ...

FDA announced on Dec. 1, 2025 that it will be providing agency staff with agentic artificial intelligence (AI) capabilities ...

Dr. Michelle Sestak joined HORIBA in 2012 after earning a PhD in physics from the University of Toledo. She specialized in spectroscopic ellipsometry for cadmium telluride thin-film solar cells.

Several 3D printing technologies are currently considered more clinically applicable, including SSE, fused deposition ...

The first patient visit has taken place for the SURMOUNT-REAL UK clinical trial of Eli Lilly and Company’s weight-loss drug, tirzepatide.